HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NE-100, a novel sigma receptor ligand: in vivo tests.

Abstract
It has been suggested that sigma receptor antagonists may be useful as antipsychotic drugs. N, N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100) is a novel compound with high affinity for the sigma receptor (IC50 = 4.16 nM), but low affinity (IC50 > 10,000 nM) for D1, D2, 5-HT1A, 5-HT2 and phencyclidine (PCP) receptors. The head-weaving behavior induced by either (+)SKF10047 or PCP was dose-dependently antagonized by NE-100 with oral ED50 at 0.27 and 0.12 mg/kg, respectively. NE-100 did not affect dopamine agonists-induced stereotyped behavior and/or hyperactivity. NE-100 failed to induce catalepsy in rats. These findings indicate that NE-100 may have antipsychotic activity without the liability of motor side effects typical of neuroleptics.
AuthorsS Okuyama, Y Imagawa, S Ogawa, H Araki, A Ajima, M Tanaka, M Muramatsu, A Nakazato, K Yamaguchi, M Yoshida
JournalLife sciences (Life Sci) Vol. 53 Issue 18 Pg. PL285-90 ( 1993) ISSN: 0024-3205 [Print] Netherlands
PMID7901723 (Publication Type: Journal Article)
Chemical References
  • Anisoles
  • Antipsychotic Agents
  • Dopamine Agents
  • Propylamines
  • Receptors, sigma
  • N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
  • SK&F 10047
  • Phenazocine
  • Phencyclidine
Topics
  • Animals
  • Anisoles (metabolism, pharmacology)
  • Antipsychotic Agents (metabolism, pharmacology)
  • Behavior, Animal (drug effects)
  • Binding, Competitive
  • Catalepsy (chemically induced)
  • Dopamine Agents (pharmacology)
  • Drug Interactions
  • Locomotion (drug effects)
  • Male
  • Phenazocine (analogs & derivatives, pharmacology)
  • Phencyclidine (pharmacology)
  • Propylamines (metabolism, pharmacology)
  • Radioligand Assay
  • Rats
  • Rats, Inbred Strains
  • Rats, Wistar
  • Receptors, sigma (antagonists & inhibitors)
  • Stereotyped Behavior (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: